This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Thursday's Small-Cap Winners & Losers

Fuwei Films (FFHL - Get Report), which makes plastic films for packaging and other uses, soared more than 22% Thursday after the company posted $7.88 per-share 2006 earnings on sales that leapt 26.2% year over year to $55.9 million. Shares were rising $2.19 to $11.98.

Shares of Corcept Therapeutics (CORT - Get Report) were leaping after the California-based biotech was accepted into the Nasdaq Capital Market, the exchange's small-cap index, in a switch from the Nasdaq Global Market. The change will effect at market open on Monday. Shares were up 19 cents, or 15.7%, to $1.40.

United Retail Group (URGI) posted a drop in adjusted fiscal fourth-quarter profits. The plus-sized apparel retailer earned $2 million, or 14 cents a share (excluding items), compared with a 20-cent per-share profit last year, but analysts polled by Thomson Financial were looking for 11 cents a share. The New Jersey-based company was gaining $1.14, or 9.6%, to $13.06.

Encorium Group (ENCO), which designs and manages clinical trials for biotechs, has signed around $4.7 million in new contracts in the first quarter through its European division. The Wayne, Pa., company now expects 2007 revenue to be at the upper end of its prior outlook range between $30 million and $34 million. Shares were bouncing 28 cents, or 8.3%, to $3.66.

Heelys (HLYS), maker of children's hybrid sneaker-skates with removable wheels, rose on a Wachovia upgrade to outperform from market perform. The analyst cited high demand for the shoes and said the Texas-based company may top the Street's first-quarter income target of 18 cents a share. Heelys stock was adding $2.58, or 9.3%, to $30.37.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ENCO $0.00 0.00%
CORT $5.24 0.00%
CUTR $14.41 0.00%
FFHL $0.86 0.00%
ICAD $4.06 0.00%


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs